The global gastrointestinal endoscopy devices market was valued at US$ 45.6 Billion in 2022, and is projected to reach US$ 81.0 Billion by 2030, growing at a CAGR of 7.5% from 2023 to 2030. The global gastrointestinal endoscopy device market refers to the market for medical devices used to perform endoscopic procedures in the gastrointestinal (GI) tract. These procedures involve inserting an endoscope into the GI tract to examine, diagnose, and treat various conditions affecting the digestive system.

The market for gastrointestinal endoscopy devices is driven by the increasing prevalence of digestive disorders, such as gastroesophageal reflux disease (GERD), inflammatory bowel disease (IBD), and colorectal cancer, as well as the growing aging population. Technological advancements in endoscopy devices, such as the development of capsule endoscopy and virtual endoscopy, have also contributed to the growth of this market.

North America and Europe are the largest markets for gastrointestinal endoscopy devices, with Asia Pacific expected to exhibit the highest growth rate due to the increasing adoption of endoscopy procedures in emerging economies such as China and India. Key players in the market include Olympus Corporation, Boston Scientific Corporation, Fujifilm Holdings Corporation, and Medtronic plc.

Market Dynamics

Driving Factors

The driving factors behind the growth of the global gastrointestinal endoscopy device market include:

Technological advancements: The development of new and improved endoscopy devices, such as capsule endoscopy and virtual endoscopy, has greatly expanded the capabilities of endoscopy and made it a more effective tool for diagnosing and treating digestive disorders.

Increasing adoption of minimally invasive procedures: Endoscopy is a minimally invasive procedure that offers several advantages over traditional surgery, such as shorter recovery times and reduced risk of complications. As a result, there has been a growing trend towards the adoption of endoscopic procedures, further driving the demand for gastrointestinal endoscopy devices.

Favorable reimbursement policies: In many countries, endoscopic procedures are reimbursed by insurance companies, making them more accessible to patients. This has led to an increase in demand for endoscopic procedures and, consequently, for gastrointestinal endoscopy devices.

Restraining Factors

There are several factors that may restrain the growth of the global gastrointestinal endoscopy device market, including:

Availability of alternative diagnostic and treatment methods: While endoscopy is a valuable diagnostic and treatment tool for many digestive disorders, there are alternative methods, such as imaging tests and medication, that can be used for some conditions. This may limit the demand for endoscopy procedures and gastrointestinal endoscopy devices.

Lack of skilled healthcare providers: Endoscopic procedures require specialized training and expertise, and there is a shortage of skilled healthcare providers who are able to perform these procedures. This can limit the availability of endoscopy services and the adoption of gastrointestinal endoscopy devices.

Regulatory challenges: The development and commercialization of gastrointestinal endoscopy devices is subject to regulatory approval in many countries. Regulatory hurdles can be a barrier to entry for new market players and may slow down the adoption of new technologies.

Challenges Factors

There are several challenges that the global gastrointestinal endoscopy device market may face, including:

Pricing pressures: Healthcare providers and insurers are placing increasing pressure on manufacturers to lower the cost of endoscopy procedures and devices. This can impact the profitability of manufacturers and limit their ability to invest in new product development and innovation.

Technological complexity: Gastrointestinal endoscopy devices are becoming increasingly complex, incorporating advanced imaging, robotics, and AI technologies. This can increase the cost and complexity of product development and manufacturing, and may limit the adoption of these technologies by healthcare providers.

COVID-19 pandemic: The COVID-19 pandemic has had a significant impact on the healthcare industry, including the gastrointestinal endoscopy device market. Elective procedures were delayed or cancelled, and healthcare providers faced supply chain disruptions and shortages of personal protective equipment (PPE). These challenges are likely to continue in the near term, and may impact the market for gastrointestinal endoscopy devices.

Opportunity Factors

There are several opportunities in the global gastrointestinal endoscopy device market, including:

Emerging economies: As emerging economies continue to develop their healthcare infrastructure, there is a growing demand for diagnostic and treatment tools for digestive disorders. This presents a significant opportunity for gastrointestinal endoscopy device manufacturers to expand into new markets.

Technological advancements: The development of new and improved endoscopy devices, such as robotic-assisted endoscopy and artificial intelligence (AI)-enabled systems, presents an opportunity for manufacturers to differentiate their products and improve patient outcomes.

Increasing focus on early detection: The importance of early detection and treatment of digestive disorders is increasingly recognized, particularly in the case of colorectal cancer. This presents an opportunity for gastrointestinal endoscopy device manufacturers to develop new products and services that improve the accuracy and effectiveness of early detection.

Growing demand for personalized medicine: There is a growing trend towards personalized medicine, where treatments are tailored to individual patient needs. This presents an opportunity for gastrointestinal endoscopy device manufacturers to develop products and services that are customized to individual patient needs and preferences.

Telemedicine: The use of telemedicine has grown significantly in recent years, and this presents an opportunity for gastrointestinal endoscopy device manufacturers to develop remote monitoring and diagnostic tools that can be used by healthcare providers in remote or underserved areas.

Segmentation Analysis

Product Type Outlook

Endoscopes are the most common type of gastrointestinal endoscopy devices used for diagnosis and treatment of gastrointestinal diseases. This segment can be further divided into flexible endoscopes, rigid endoscopes, and capsule endoscopes. Visualization systems are used to provide high-quality images and videos of the gastrointestinal tract during endoscopic procedures. This segment can be further divided into video processors, cameras, and monitors.

Hemostasis devices are used to stop bleeding in the gastrointestinal tract during endoscopic procedures. This segment can be further divided into clips, hemostatic agents, and electrocautery devices. Other devices in the gastrointestinal endoscopy device market include cleaning brushes, overtube, balloons, and others.

The market for gastrointestinal endoscopy devices is expected to grow due to the increasing prevalence of gastrointestinal diseases and the rising adoption of minimally invasive endoscopic procedures. The demand for endoscopic ultrasound devices, in particular, is expected to grow due to their high diagnostic accuracy and therapeutic capabilities.

End User Outlook

The global gastrointestinal endoscopy device market can be analyzed by end-use segments as follows:

Hospitals are the largest end-use segment for gastrointestinal endoscopy devices. Hospitals are equipped with advanced endoscopy systems that enable the diagnosis and treatment of gastrointestinal disorders. Additionally, hospitals have skilled professionals to operate these devices.

Regional Analysis

The global gastrointestinal endoscopy device market can be analyzed by region, with the following key regions:

The North American market for gastrointestinal endoscopy devices is mature and highly competitive. The United States is the largest market in the region, driven by a large patient population, favorable reimbursement policies, and high healthcare spending.

The Latin American market for gastrointestinal endoscopy devices is growing, driven by increasing demand for diagnostic and therapeutic procedures and growing healthcare infrastructure. Brazil and Mexico are the largest markets in the region. The Middle East and Africa market for gastrointestinal endoscopy devices is relatively small but is expected to grow in the coming years, driven by increasing healthcare spending and demand for diagnostic and therapeutic procedures.

Scope Of Report:

The Global Gastrointestinal Endoscopy Device Market has been segmented into:

By Product

• GI Videoscopes
• Biopsy Devices
• Endoscopic Retrograde Cholangiopancreatography Devices (ERCP)
• Capsule Endoscopy
• Endoscopic Ultrasound
• Endoscopic Mucosal Resection (EMR)
• Hemostasis Devices
• Other Product Types

By Sales Channel

• Online Retailing
• Medical Stores & Brand Outlet

By End-User

• Hospitals, 
• Clinics & Dialysis Centers
• Ambulatory Surgical Center

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
  • Denmark
  • Finland
  • Iceland
  • Sweden
  • Norway
  • Belgium
  • The Netherlands
  • Luxembourg
• Germany
• France
• Italy
• Spain
• UK
• Nordic Countries
• Benelux Union
• Rest of Europe
• Asia-Pacific
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Rest of Southeast Asia
• Japan
• China
• India
• Australia
• South Korea
• Southeast Asia
• Rest of Asia-Pacific
• The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America

Market Players 

The global gastrointestinal endoscopy devices market is highly competitive and fragmented, with numerous players vying for market share. Some of the key companies in the market are:

• Boston Scientific
• Medtronic
• Fujifilm Holdings Corporation
• CONMED Corporation
• Stryker Corporation
• Johnson & Johnson
• Olympus, Cook Group
• Becton, Dickinson
• B. Braun Melsungen.

Olympus Corporation is a leading manufacturer of gastrointestinal endoscopy devices, offering a wide range of products for diagnostic and therapeutic procedures. Fujifilm Holdings Corporation is a diversified healthcare and technology company that offers a range of endoscopy devices for gastrointestinal procedures.

Pentax Medical is a medical device company that offers a range of gastrointestinal endoscopy devices, including video endoscopes, ultrasound endoscopes, and other diagnostic and therapeutic devices. Johnson & Johnson is a global healthcare company that offers a range of medical devices, including gastrointestinal endoscopy devices for both diagnostic and therapeutic procedures.

Strategic Developments

There have been several recent developments in the gastrointestinal endoscopy device market in terms of mergers, acquisitions, and investments. Some of the notable ones include:

Boston Scientific Corporation acquired Creo Medical Group plc in March 2021 for $510 million, expanding its product offerings in the field of advanced endoscopy.

Olympus Corporation announced in May 2021 that it was selling its medical business to Japan Industrial Partners Inc. for $1.7 billion, including its gastrointestinal endoscopy business.

Fujifilm Holdings Corporation announced in February 2021 that it was acquiring a majority stake in medwork GmbH, a Germany-based medical technology company that specializes in gastrointestinal endoscopy.

Cook Medical LLC announced in October 2020 that it was acquiring the endoscopy business of Zeiss Group, a German optical systems manufacturer, to expand its product offerings in the field of advanced endoscopy.

Medtronic plc announced in July 2020 that it was investing $40 million in Atlantic Therapeutics Group Ltd., a company that develops non-invasive pelvic floor muscle strengthening devices for urinary and fecal incontinence.